Dr. Bhishamjit S. Chera

Bhisham Chera, M.D., is a board-certified radiation oncologist, Vice Chairman for Safety and Quality Assurance in the Department of Radiation Oncology, and the Wendy \& Keith Wellin Endowed Chair in Radiation Oncology. His primary clinical emphasis is in the treatment of head and neck, and skin cancers.Dr. Chera's academic interests are in head and neck oncology and health care quality and safety improvement. He is nationally and internationally known for his pioneering work in evaluating reduced intensity radiation and chemotherapy treatments for patients with human papillomavirus (HPV) associated with throat cancers. He has also co-invented a blood-based biomarker for HPV-associated cancers.As of 2022, Dr. Chera has published over 100 manuscripts, ten book chapters, presented his research at over 100 national meetings, and has given 70 invited talks. His contributions to the field of patient safety and quality improvement include 22 publications, membership on the Radiation Oncology Health Advisory Committee, and serving as an international expert for the International Atomic Energy Agency.

Dr. Chera is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), and Sinus Cancer.

He is actively involved in clinical research, co-authoring 130 peer reviewed articles and participating in 8 clinical trials. Dr. Chera is currently accepting new patients.